Header bg
  • Users Online: 509
  • Print this page
  • Email this page
Header bg
Year : 2017  |  Volume : 1  |  Issue : 3  |  Page : 77-82

Anaesthesia for ECT in neuroleptic malignant syndrome - what is ideal?

Miri General Hospital, Sarawak, Malaysia

Correspondence Address:
Jaishree Santhirasegaran
Santhirasegaran, Anesthesiology and Intensive Care Unit (ICU), Hospital Miri, Jalan Cahaya, 98000, Miri, Sarawak
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.15562/bjoa.v1i3.41

Rights and Permissions

We report a case involving a 46 year old male with schizophrenia who presented with fever, inability to speak, sialorrhoea, limb stiffness, profuse sweating, tremors and rigidity of bilateral upper and lower limbsfollowing an increase in dosage of his antipsychotics. A provisional diagnosis of neuroleptic malignant syndrome (NMS) was made based on the Levensen criteria. His antipsychotics were promptly discontinued and he was transferred to ICU for critical care support. We utilised lorazepam and prescribed bromocriptine and his NMS symptoms improved. However, in view of residual catatonic symptoms, decision was made to commence ECT. A combination of rocuronium sugammadex was used successfully in all his ECT procedures and found to be an excellent alternative to succinycholine in this patient.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded106    
    Comments [Add]    

Recommend this journal